We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Intuitive Surgical, Inc. (ISRG) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Read MoreHide Full Article
Intuitive Surgical, Inc. (ISRG - Free Report) reported $1.76 billion in revenue for the quarter ended June 2023, representing a year-over-year increase of 15.4%. EPS of $1.42 for the same period compares to $1.14 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $1.73 billion, representing a surprise of +1.35%. The company delivered an EPS surprise of +7.58%, with the consensus EPS estimate being $1.32.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Intuitive Surgical, Inc. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Total System Units Placed - Total Company: 331 versus the six-analyst average estimate of 280.8.
Da Vinci Installed Surgical System Base: 8042 compared to the 8007.18 average estimate based on five analysts.
Total System Units Placed - United States: 157 versus the three-analyst average estimate of 134.21.
Total System Units Placed - Outside of the United States: 174 versus the two-analyst average estimate of 141.52.
Instruments and accessories Revenue- United States: $763.30 million versus the two-analyst average estimate of $722.82 million. The reported number represents a year-over-year change of +22.1%.
Systems Revenue- Outside of the United States: $202.90 million versus $183.71 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +29.2% change.
Instruments and accessories Revenue- Outside of the United States: $312.60 million compared to the $297.89 million average estimate based on two analysts. The reported number represents a change of +15.7% year over year.
Systems Revenue- United States: $189.80 million versus $253.76 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -12.9% change.
Revenue- Products (Instruments and Systems): $1.47 billion versus $1.44 billion estimated by eight analysts on average. Compared to the year-ago quarter, this number represents a +15.6% change.
Revenue- Services: $287.30 million versus the eight-analyst average estimate of $283.96 million. The reported number represents a year-over-year change of +14.1%.
Revenue- Systems: $392.70 million versus $416.48 million estimated by eight analysts on average. Compared to the year-ago quarter, this number represents a +4.7% change.
Revenue- Instruments and accessories: $1.08 billion versus $1.03 billion estimated by eight analysts on average. Compared to the year-ago quarter, this number represents a +20.2% change.
Shares of Intuitive Surgical, Inc. have returned +8% over the past month versus the Zacks S&P 500 composite's +3.6% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Intuitive Surgical, Inc. (ISRG) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Intuitive Surgical, Inc. (ISRG - Free Report) reported $1.76 billion in revenue for the quarter ended June 2023, representing a year-over-year increase of 15.4%. EPS of $1.42 for the same period compares to $1.14 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $1.73 billion, representing a surprise of +1.35%. The company delivered an EPS surprise of +7.58%, with the consensus EPS estimate being $1.32.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Intuitive Surgical, Inc. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Total System Units Placed - Total Company: 331 versus the six-analyst average estimate of 280.8.
- Da Vinci Installed Surgical System Base: 8042 compared to the 8007.18 average estimate based on five analysts.
- Total System Units Placed - United States: 157 versus the three-analyst average estimate of 134.21.
- Total System Units Placed - Outside of the United States: 174 versus the two-analyst average estimate of 141.52.
- Instruments and accessories Revenue- United States: $763.30 million versus the two-analyst average estimate of $722.82 million. The reported number represents a year-over-year change of +22.1%.
- Systems Revenue- Outside of the United States: $202.90 million versus $183.71 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +29.2% change.
- Instruments and accessories Revenue- Outside of the United States: $312.60 million compared to the $297.89 million average estimate based on two analysts. The reported number represents a change of +15.7% year over year.
- Systems Revenue- United States: $189.80 million versus $253.76 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -12.9% change.
- Revenue- Products (Instruments and Systems): $1.47 billion versus $1.44 billion estimated by eight analysts on average. Compared to the year-ago quarter, this number represents a +15.6% change.
- Revenue- Services: $287.30 million versus the eight-analyst average estimate of $283.96 million. The reported number represents a year-over-year change of +14.1%.
- Revenue- Systems: $392.70 million versus $416.48 million estimated by eight analysts on average. Compared to the year-ago quarter, this number represents a +4.7% change.
- Revenue- Instruments and accessories: $1.08 billion versus $1.03 billion estimated by eight analysts on average. Compared to the year-ago quarter, this number represents a +20.2% change.
View all Key Company Metrics for Intuitive Surgical, Inc. here>>>Shares of Intuitive Surgical, Inc. have returned +8% over the past month versus the Zacks S&P 500 composite's +3.6% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.